Picture of Cellebrite DI logo

CLBT — Cellebrite DI News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapHigh Flyer

Cellebrite DI Ltd reports results for the quarter ended December 31 - Earnings Summary

* Cellebrite DI Ltd  CLBT.OQ  reported quarterly adjusted
earnings
of 10 cents​​ per share for the quarter ended December 31, lower
than the same quarter last year, when the company reported EPS
of 11 cents.  The mean expectation of eight analysts for the
quarter was for earnings of 10 cents per share. Wall Street
expected results to range from 8 cents to 11 cents per share.
    * Revenue rose 17.2% to $109.05 million from a year ago;
analysts
expected $107.18 million. 
    * Cellebrite DI Ltd's reported EPS for the quarter was 8
cents​.
    * The company reported quarterly net income of $19.27
million.
    * Cellebrite DI Ltd shares had risen by 13.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the software peer
group
is also "buy"

Wall Street's median 12-month price target for Cellebrite DI Ltd
is $24.00 
This summary was machine generated from LSEG data February 13 at
02:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      0.10           0.10           Met
 Sep. 30 2024      0.09           0.14           Beat
 Jun. 30 2024      0.05           0.10           Beat
 Mar. 31 2024      0.06           0.08           Beat

Recent news on Cellebrite DI

See all news